Resultados de la búsqueda 301-310 of 11442 for Acne vulgaris

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

  4. Uñas encarnadas - Diagnóstico y tratamiento - Mayo Clinic

    Ingrown toenail prevention and treatment. Mayo Clinic; 2014. Dinulos JGH. Nail diseases. In Habif's Clinical Dermatology. 7th ed. Elsevier; 2021. https ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Pituitary tumor registry. Rochester, Minn. The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

  8. Rosácea ocular

    Acne, rosacea, and related disorders. Habif's Clinical Dermatology. 7th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed May 12, 2020. Salmon JF ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Treatment options are then defined according to the disease burden strata. Treatment is allocated by randomisation. Patients may be allocated to one of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...